INS and metabolic dysfunction-associated steatotic liver disease: In the subsequent sections, we will delve into a comprehensive examination of BMD, insulin levels, and markers of subclinical inflammation, aiming to provide a clearer understanding of the interplay between NAFLD and these parameters.